# Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation

> **NCT03378102** · EARLY_PHASE1 · RECRUITING · sponsor: **Mari Dallas** · enrollment: 20 (estimated)

## Conditions studied

- Allogeneic Hematopoietic Stem Cell Transplantation

## Interventions

- **BIOLOGICAL:** IFN-gamma-secreting HAdV antigen specific T cells

## Key facts

- **NCT ID:** NCT03378102
- **Lead sponsor:** Mari Dallas
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-04
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03378102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03378102, "Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03378102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*